HIV-associated tuberculosis: Relationship between disease severity and the sensitivity of new sputum-based and urine-based diagnostic assays

BMC Medicine

Volumn 11, Issue 1, 2013, Pages

  Lawn, Stephen D ^a,b   Kerkhoff, Andrew D ^a,c   Vogt, Monica ^a   Wood, Robin ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

Africa; Diagnosis; HIV; Lipoarabinomannan; Mortality; Screening; Tuberculosis; Urine; Xpert

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; C REACTIVE PROTEIN; HEMOGLOBIN;

ADULT; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEMOGLOBIN DETERMINATION; HIV ASSOCIATED TUBERCULOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LIQUID CULTURE; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SOUTH AFRICA; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS; SPUTUM SMEAR; TUBERCULOSIS; URINALYSIS; EVALUATION STUDY; METHODOLOGY; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PATHOLOGY; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SPUTUM; URINE;

ADULT; BACTERIOLOGICAL TECHNIQUES; FEMALE; HIV INFECTIONS; HUMANS; MALE; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; SPUTUM; TUBERCULOSIS; URINE;

EID: 84886422759     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/1741-7015-11-231     Document Type: Article

References (38)

1. World Health Organization Global Tuberculosis Control Report 2012 2012, Geneva: World Health Organization, [http://apps.who.int/iris/bitstream/10665/75938/1/9789241564502_eng.pdf], World Health Organization.
2. Lucas SB, Hounnou A, Peacock C, Beaumel A, Djomand G, N'Gbichi JM, Yeboue K, Honde M, Diomande M, Giordano C. The mortality and pathology of HIV infection in a west African city. AIDS 1993, 7:1569-1579. 10.1097/00002030-199312000-00005, 7904450.
3. Rana FS, Hawken MP, Mwachari C, Bhatt SM, Abdullah F, Ng'ang'a LW, Power C, Githui WA, Porter JD, Lucas SB. Autopsy study of HIV-1-positive and HIV-1-negative adult medical patients in Nairobi, Kenya. J Acquir Immune Defic Syndr 2000, 24:23-29.
4. Cohen T, Murray M, Wallengren K, Alvarez GG, Samuel EY, Wilson D. The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study. PLoS Med 2010, 7:e1000296. 10.1371/journal.pmed.1000296, 2889914, 20582324.
5. Wong EB, Omar T, Setlhako GJ, Osih R, Feldman C, Murdoch DM, Martinson NA, Bangsberg DR, Venter WD. Causes of death on antiretroviral therapy: a post-mortem study from South Africa. PLoS ONE 2012, 7:e47542. 10.1371/journal.pone.0047542, 3472995, 23094059.
6. Lawn SD, Harries AD, Meintjes G, Getahun H, Havlir DV, Wood R. Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2012, 26:2121-2133. 10.1097/QAD.0b013e3283565dd1, 3819503, 22695302.
7. Lawn SD, Wood R. Tuberculosis in antiretroviral treatment services in resource-limited settings: addressing the challenges of screening and diagnosis. J Infect Dis 2011, 204:S1159-S1167. 10.1093/infdis/jir411, 3192543, 21996698.
8. Reid MJ, Shah NS. Approaches to tuberculosis screening and diagnosis in people with HIV in resource-limited settings. Lancet Infect Dis 2009, 9:173-184. 10.1016/S1473-3099(09)70043-X, 19246021.
9. Getahun H, Kittikraisak W, Heilig CM, Corbett EL, Ayles H, Cain KP, Grant AD, Churchyard GJ, Kimerling M, Shah S, Lawn SD, Wood R, Maartens G, Granich R, Date AA, Varma JK. Development of a standardized screening rule for tuberculosis in people living with HIV in resource-constrained settings: individual participant data meta-analysis of observational studies. PLoS Med 2011, 8:e1000391. 10.1371/journal.pmed.1000391, 3022524, 21267059.
10. Cain KP, McCarthy KD, Heilig CM, Monkongdee P, Tasaneeyapan T, Kanara N, Kimerling ME, Chheng P, Thai S, Sar B, Phanuphak P, Teeratakulpisarn N, Phanuphak N, Nguyen HD, Hoang TQ, Le HT, Varma JK. An algorithm for tuberculosis screening and diagnosis in people with HIV. N Engl J Med 2010, 362:707-716. 10.1056/NEJMoa0907488, 20181972.
11. Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A. Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 2013, 13:349-361. 10.1016/S1473-3099(13)70008-2, 23531388.
12. UNITAID Secretariat Tuberculosis Diagnostic Technology Landscape 2012 2012, Geneva: World Health Organization, [http://www.unitaid.eu/images/marketdynamics/publications/UNITAID-Tuberculosis-Landscape_2012.pdf], UNITAID Secretariat.
13. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic accuracy of a low-cost, urine antigen, point-of-care screening assay for HIV-associated pulmonary tuberculosis before antiretroviral therapy: a descriptive study. Lancet Infect Dis 2012, 12:201-209. 10.1016/S1473-3099(11)70251-1, 3315025, 22015305.
14. Lawn SD, Brooks SV, Kranzer K, Nicol MP, Whitelaw A, Vogt M, Bekker LG, Wood R. Screening for HIV-associated tuberculosis and rifampicin resistance before antiretroviral therapy using the Xpert MTB/RIF assay: a prospective study. PLoS Med 2011, 8:e1001067. 10.1371/journal.pmed.1001067, 3144215, 21818180.
15. Lawn SD, Kerkhoff AD, Vogt M, Wood R. High diagnostic yield of tuberculosis from screening urine samples from HIV-infected patients with advanced immunodeficiency using the Xpert MTB/RIF assay. J Acquir Immune Defic Syndr 2012, 60:289-294. 10.1097/QAI.0b013e318258c6af, 3384719, 22531759.
16. Lawn SD, Myer L, Bekker LG, Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 2006, 20:1605-1612. 10.1097/01.aids.0000238406.93249.cd, 16868441.
17. Lawn SD, Myer L, Orrell C, Bekker LG, Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 2005, 19:2141-2148. 10.1097/01.aids.0000194802.89540.e1, 16284464.
18. Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa. PLoS ONE 2013, 8:e55824. 10.1371/journal.pone.0055824, 3572168, 23418463.
19. Gupta A, Wood R, Kaplan R, Bekker LG, Lawn SD. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community. PLoS One 2012, 7:e34156. 10.1371/journal.pone.0034156, 3316623, 22479548.
20. Dawson R, Masuka P, Edwards DJ, Bateman ED, Bekker LG, Wood R, Lawn SD. Chest radiograph reading and recording system: evaluation for tuberculosis screening in patients with advanced HIV. Int J Tuberc Lung Dis 2010, 14:52-58. 3647461, 20003695.
21. Den Boon S, Bateman ED, Enarson DA, Borgdorff MW, Verver S, Lombard CJ, Irusen E, Beyers N, White NW. Development and evaluation of a new chest radiograph reading and recording system for epidemiological surveys of tuberculosis and lung disease. Int J Tuberc Lung Dis 2005, 9:1088-1096.
22. World Health Organization Haemoglobin Concentrations for the Diagnosis of Anaemia and Assessment of Severity 2011, Geneva: World Health Organization, (WHO/NMH/NHD/MNM/11.1). [http://www.who.int/vmnis/indicators/haemoglobin.pdf], World Health Organization.
23. Lawn SD, Kerkhoff AD, Wood R. Progression of subclinical culture-positive tuberculosis to symptomatic disease in HIV-infected individuals. AIDS 2011, 25:2190-2191.
24. Oni T, Burke R, Tsekela R, Bangani N, Seldon R, Gideon HP, Wood K, Wilkinson KA, Ottenhoff TH, Wilkinson RJ. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 2011, 66:669-673. 10.1136/thx.2011.160168, 3142344, 21632522.
25. Lawn SD, Kerkhoff AD, Vogt M, Wood R. Diagnostic and prognostic value of serum C-reactive protein for screening for HIV-associated tuberculosis. Int J Tuberc Lung Dis 2013, 17:636. 10.5588/ijtld.12.0811, 23575330.
26. Lawn SD, Harries AD, Anglaret X, Myer L, Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 2008, 22:1897-1908. 10.1097/QAD.0b013e32830007cd, 3816249, 18784453.
27. Maruza M, Albuquerque MF, Braga MC, Barbosa MT, Byington R, Coimbra I, Moura LV, Batista JD, Diniz GT, Miranda-Filho DB, Lacerda HR, Rodrigues LC, Ximenes RA. Survival of HIV-infected patients after starting tuberculosis treatment: a prospective cohort study. Int J Tuberc Lung Dis 2012, 16:618-624.
28. Lewis DK, Peters RP, Schijffelen MJ, Joaki GR, Walsh AL, Kublin JG, Kumwenda J, Kampondeni S, Molyneux ME, Zijlstra EE. Clinical indicators of mycobacteraemia in adults admitted to hospital in Blantyre, Malawi. Int J Tuberc Lung Dis 2002, 6:1067-1074.
29. Lawn SD, Kerkhoff AD, Wood R. Location of Xpert(R) MTB/RIF in centralised laboratories in South Africa undermines potential impact. Int J Tuberc Lung Dis 2012, 16:701. 10.5588/ijtld.12.0131, 22507934.
30. Cohen G, Drain P, Noubary F, Cloete C, Nixon K, Parker G, Bassett I. Diagnostic Delays Associated with Xpert MTB/RIF Assay in a Centralized Laboratory for Pulmonary TB among HIV-positive Adults in South Africa 2013, Atlanta, GA, USA: Program and abstracts of the 20th Conference on Retroviruses and Opportunistic Infections, Abstract #846.
31. Gupta RK, Lawn SD, Bekker LG, Caldwell J, Kaplan R, Wood R. Impact of human immunodeficiency virus and CD4 count on tuberculosis diagnosis: analysis of city-wide data from Cape Town, South Africa. Int J Tuberc Lung Dis 2013, 17:1014-1022. 10.5588/ijtld.13.0032, 23827024.
32. Lawn SD, Kerkhoff AD, Pahlana P, Vogt M, Wood R. Diagnostic yield of tuberculosis using sputum induction in HIV-positive patients before antiretroviral therapy [Short communication]. Int J Tuberc Lung Dis 2012, 16:1354. 10.5588/ijtld.12.0174, 22862896.
33. Peter J, Green C, Hoelscher M, Mwaba P, Zumla A, Dheda K. Urine for the diagnosis of tuberculosis: current approaches, clinical applicability, and new developments. Curr Opin Pulm Med 2010, 16:262-270. 10.1097/MCP.0b013e328337f23a, 20375787.
34. Lawn SD. Point-of-care detection of lipoarabinomannan (LAM) in urine for diagnosis of HIV-associated tuberculosis: a state of the art review. BMC Infect Dis 2012, 12:103. 10.1186/1471-2334-12-103, 3423001, 22536883.
35. Shah M, Variava E, Holmes CB, Coppin A, Golub JE, McCallum J, Wong M, Luke B, Martin DJ, Chaisson RE, Dorman SE, Martinson NA. Diagnostic accuracy of a urine lipoarabinomannan test for tuberculosis in hospitalized patients in a High HIV prevalence setting. J Acquir Immune Defic Syndr 2009, 52:145-151. 10.1097/QAI.0b013e3181b98430, 2815254, 19692904.
36. Peter JG, Theron G, Muchinga TE, Govender U, Dheda K. The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce. PLoS ONE 2012, 7:e39966. 10.1371/journal.pone.0039966, 3392260, 22815718.
37. Dorman SE, Chihota VN, Lewis JJ, Shah M, Clark D, Grant AD, Churchyard GJ, Fielding KL. Performance characteristics of the Cepheid Xpert MTB/RIF test in a tuberculosis prevalence survey. PLoS ONE 2012, 7:e43307. 10.1371/journal.pone.0043307, 3419700, 22905254.
38. O'Grady J, Bates M, Chilukutu L, Mzyece J, Cheelo B, Chilufya M, Mukonda L, Mumba M, Tembo J, Chomba M, Kapata N, Maeurer M, Rachow A, Clowes P, Hoelscher M, Mwaba P, Zumla A. Evaluation of the Xpert MTB/RIF assay at a tertiary care referral hospital in a setting where tuberculosis and HIV infection are highly endemic. Clin Infect Dis 2012, 55:1171-1178. Erratum in: Clin Infect Dis 2013, 56:313, 10.1093/cid/cis631, 22806590.